"Misonix is pleased to demonstrate its commitment to the rapidly expanding wound care market by supporting important educational programs like the Clinical Symposium on Advances in Skin and Wound Care," said Michael A. McManus, Jr., President and Chief Executive Officer of Misonix. "We believe our wound care platform makes an important contribution to improving patient outcomes and we are pleased when data is presented that validates our investment in wound care research and development."About Misonix:
Misonix Exhibits At 26th Annual Clinical Symposium On Advances In Skin And Wound Care
Check Out Our Best Services for Investors
Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts
David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.
Every recommendation goes through 3 layers of intense scrutinyquantitative, fundamental and technical analysisto maximize profit potential and minimize risk.
Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.